Analystreport

BeiGene, Ltd. (NASDAQ: BGNE) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $120.00 price target on the stock, up previously from $77.00.

BeiGene, Ltd. - American Depositary Shares  (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report